6.970

-0.230 (-3.19%)
Range 6.840 - 7.150   (4.53%)
Open 7.150
Previous Close 7.200
Buy Price 6.940
Buy Volume 11
Sell Price 7.000
Sell Volume 8
Volume 319,146
Value -
Remark
Measurement Type Value
EPS (USD) -1.026
Trailing EPS (USD) -1.075
NAV (USD) 5.406
Cash In Hand (USD) 1.227
Dividend -
Dividend Yield (%) -
PE -
Trailing PE -
Price / NAV 1.332
Price / Cash In Hand 5.869
Issued & Paid-up Shares 25,397,300
Treasury Shares -
Market Cap (M) 182.861
Par Value (USD) n.a.
Beta - 75 Days 1.402
R-Squared - 75 Days(%) 7.39
Beta - 500 Days 0.793
R-Squared - 500 Days(%) 0.21
ISIN Code -
Under CPF Investment Scheme (CPFIS) No
Index Components
Delayed prices. Updated at 22 Jun 2021 00:52.
Data powered by

Upcoming Events

* Stock event date based on US timezone.

Earnings

Release Date 05 Aug 2021
View All Events

About HEAT BIOLOGICS INC

Heat Biologics, Inc. (Heat Biologics) is a development-stage biopharmaceutical company engaged in the development of allogeneic, off-the-shelf cellular therapeutic vaccines to combat a range of cancers and infectious diseases. Its ImmunePan Antigen Cytotoxic Therapy (ImPACT) is being designed to deliver live, genetically-modified, irradiated human cells which are reprogrammed to pump out a range of cancer-associated antigens together with a immune adjuvant called gp96 to educate and activate a cancer patient�s immune system to recognize and kill cancerous cells. Its primary product candidates are HS-110 and HS-410. It is also developing ImPACT therapeutic vaccines for breast cancer and ovarian cancer.

Loading Chart...